Literature DB >> 31295359

Greater parental comfort with lower glucose targets in young children with Type 1 diabetes using continuous glucose monitoring.

M A Van Name1, K M Miller2, P V Commissariat3, A L Whitehouse3, K R Harrington3, B J Anderson4, M G Mantravadi5, W Levy4, D J DeSalvo4, W V Tamborlane1, M E Hilliard4, L M Laffel3, L A DiMeglio5.   

Abstract

Entities:  

Year:  2019        PMID： 31295359      PMCID： PMC7027357          DOI： 10.1111/dme.14074

Source DB:  PubMed          Journal:  Diabet Med        ISSN： 0742-3071            Impact factor:   4.359


× No keyword cloud information.
  7 in total

1.  ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes.

Authors:  Linda A DiMeglio; Carlo L Acerini; Ethel Codner; Maria E Craig; Sabine E Hofer; Kubendran Pillay; David M Maahs
Journal:  Pediatr Diabetes       Date:  2018-10       Impact factor: 4.866

2.  Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.

Authors:  Kellee M Miller; Nicole C Foster; Roy W Beck; Richard M Bergenstal; Stephanie N DuBose; Linda A DiMeglio; David M Maahs; William V Tamborlane
Journal:  Diabetes Care       Date:  2015-06       Impact factor: 19.112

3.  Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes.

Authors:  Eva Tsalikian; Larry Fox; Stuart Weinzimer; Bruce Buckingham; Neil H White; Roy Beck; Craig Kollman; Dongyuan Xing; Katrina Ruedy
Journal:  Pediatr Diabetes       Date:  2011-12-13       Impact factor: 4.866

4.  A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years.

Authors:  Nelly Mauras; Roy Beck; Dongyuan Xing; Katrina Ruedy; Bruce Buckingham; Michael Tansey; Neil H White; Stuart A Weinzimer; William Tamborlane; Craig Kollman
Journal:  Diabetes Care       Date:  2011-12-30       Impact factor: 19.112

5.  Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative.

Authors:  Daniel J DeSalvo; Kellee M Miller; Julia M Hermann; David M Maahs; Sabine E Hofer; Mark A Clements; Eggert Lilienthal; Jennifer L Sherr; Martin Tauschmann; Reinhard W Holl
Journal:  Pediatr Diabetes       Date:  2018-07-01       Impact factor: 4.866

6.  Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes.

Authors:  Roy W Beck; Bruce Buckingham; Kellee Miller; Howard Wolpert; Dongyuan Xing; Jennifer M Block; H Peter Chase; Irl Hirsch; Craig Kollman; Lori Laffel; Jean M Lawrence; Kerry Milaszewski; Katrina J Ruedy; William V Tamborlane
Journal:  Diabetes Care       Date:  2009-08-12       Impact factor: 19.112

7.  Type 1 diabetes through the life span: a position statement of the American Diabetes Association.

Authors:  Jane L Chiang; M Sue Kirkman; Lori M B Laffel; Anne L Peters
Journal:  Diabetes Care       Date:  2014-07       Impact factor: 19.112
  7 in total
  3 in total

Review 1.  Use of Diabetes Technology in Children: Role of Structured Education for Young People with Diabetes and Families.

Authors:  Hannah R Desrochers; Alan T Schultz; Lori M Laffel
Journal:  Endocrinol Metab Clin North Am       Date:  2020-03       Impact factor: 4.741

2.  Implementation and Preliminary Feasibility of an Individualized, Supportive Approach to Behavioral Care for Parents of Young Children Newly Diagnosed With Type 1 Diabetes.

Authors:  Carrie Tully; Lauren Clary; Maureen Monaghan; Wendy Levy; Marisa E Hilliard; Randi Streisand
Journal:  Cogn Behav Pract       Date:  2020-08-05

3.  Development and delivery of a brief family behavioral intervention to support continuous glucose monitor use in young children with type 1 diabetes.

Authors:  Marisa E Hilliard; Persis V Commissariat; Lauren Kanapka; Lori M Laffel; Wendy Levy; Kara Harrington; Barbara J Anderson; Kellee M Miller; Linda A DiMeglio
Journal:  Pediatr Diabetes       Date:  2022-05-19       Impact factor: 3.409
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.